| |
| Physical Characters and Index |
English name: BMS-986165
CAS number: 1609392-27-9
Molecular formula: C20H22N8O3
Molecular weight: 422.45 |
| |
| Use and description |
| Deucravacitinib (BMS-986165) is the first and only novel, oral, selective tyrosine kinase 2 (TYK2) inhibitor in clinical studies across multiple immune-mediated diseases. Deucravacitinib’s selectivity is driven by a unique mechanism of action that is distinct from other kinase inhibitors. |
|
